東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Gut Hormone Regulation of Hepatic an...

Hoffman, Simon Steinbring.

Linked to FindBook

Google Book

Amazon

博客來

Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production./
Author:	Hoffman, Simon Steinbring.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2023,
Description:	212 p.
Notes:	Source: Dissertations Abstracts International, Volume: 85-01, Section: B.
Contained By:	Dissertations Abstracts International85-01B.
Subject:	Physiology. -
Online resource:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30420480
ISBN:	9798379763503

Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production.
Hoffman, Simon Steinbring.

Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production. - Ann Arbor : ProQuest Dissertations & Theses, 2023 - 212 p.

Source: Dissertations Abstracts International, Volume: 85-01, Section: B.

Thesis (Ph.D.)--University of Toronto (Canada), 2023.

Dyslipidemia is a key component of insulin resistance, which results in the overproduction of hepatic and intestinal apolipoprotein (apo)B-containing lipoprotein particles. These particles are catabolized down into highly proatherogenic remnants. Several gut-derived peptides have been identified as regulators of energy metabolism; one such peptide is the incretin hormone glucagon-like peptide (GLP)-1. Our laboratory has previously demonstrated that GLP-1 can signal both centrally and peripherally to reduce postprandial and fasting lipoprotein secretion. Here, I examine a novel vagal neuroendocrine signalling pathway by which native GLP-1 may exert its anti-lipemic effects. Furthermore, I demonstrate a novel role for other gut-derived peptides in regulating intestinal lipoprotein production. Portal vein injections of GLP-1(7-36) into Syrian golden hamsters revealed a site-specific anti-lipemic role for native GLP-1. This effect was lost after GLP-1R antagonism, and in a GLP-1R KO hamster model. The suppressive effects of portal GLP-1 on intestinal lipoprotein excursion were also lost after chemical, pharmacological, surgical, or selective denervation of the vagus nerve - together identifying the vagus nerve as a key component of GLP-1's endogenous signalling pathway. Moreover, we demonstrate a role for nodose ganglia GLP-1R-containing neurons in propagating anti-lipemic viscerosensory signals. These data are complimented by the finding of portal and nodose ganglia GLP-1 resistance following diet-induced insulin resistance, suggesting loss of this vagal GLP-1 signalling pathway may occur at the advent of diabetic dyslipidemia. The role of other gut- derived anorexigenic hormones were also investigated, and we identified that Peptide YY, oxytocin, and cholecystokinin (CCK) also exert a suppressive effect on postprandial lipoprotein metabolism. Importantly, we also delineate the effect of CCK receptor signalling from bile acid release on postprandial lipemia. This in combination with data showing CCKs effects are lost in GLP-1R KO hamsters suggests that CCK may exert its effects though bile acid-mediated increases in GLP-1 secretion. Overall, the data presented here supports a key role for GLP-1 receptors on the portal vein afferent neurons in modulating intestinal fat absorption and lipoprotein production and identifies other gut-derived peptides as novel regulators of postprandial lipemia. Insights from these data may support identification of potential drug targets for treatment of diabetic dyslipidemia.

ISBN: 9798379763503Subjects--Topical Terms:

518431
Physiology.
Subjects--Index Terms:

Chylomicron

Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production.
LDR:03697nmm a2200397 4500 001 2401057
005 20241015112510.5
006 m o d
007 cr#unu||||||||
008 251215s2023 ||||||||||||||||| ||eng d
020 $a 9798379763503
035 $a (MiAaPQ)AAI30420480
035 $a AAI30420480
035 $a 2401057
040 $a MiAaPQ $c MiAaPQ
100 1 $a Hoffman, Simon Steinbring. $3 3771119
245 1 0 $a Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2023
300 $a 212 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-01, Section: B.
500 $a Advisor: Adeli, Khosrow.
502 $a Thesis (Ph.D.)--University of Toronto (Canada), 2023.
520 $a Dyslipidemia is a key component of insulin resistance, which results in the overproduction of hepatic and intestinal apolipoprotein (apo)B-containing lipoprotein particles. These particles are catabolized down into highly proatherogenic remnants. Several gut-derived peptides have been identified as regulators of energy metabolism; one such peptide is the incretin hormone glucagon-like peptide (GLP)-1. Our laboratory has previously demonstrated that GLP-1 can signal both centrally and peripherally to reduce postprandial and fasting lipoprotein secretion. Here, I examine a novel vagal neuroendocrine signalling pathway by which native GLP-1 may exert its anti-lipemic effects. Furthermore, I demonstrate a novel role for other gut-derived peptides in regulating intestinal lipoprotein production. Portal vein injections of GLP-1(7-36) into Syrian golden hamsters revealed a site-specific anti-lipemic role for native GLP-1. This effect was lost after GLP-1R antagonism, and in a GLP-1R KO hamster model. The suppressive effects of portal GLP-1 on intestinal lipoprotein excursion were also lost after chemical, pharmacological, surgical, or selective denervation of the vagus nerve - together identifying the vagus nerve as a key component of GLP-1's endogenous signalling pathway. Moreover, we demonstrate a role for nodose ganglia GLP-1R-containing neurons in propagating anti-lipemic viscerosensory signals. These data are complimented by the finding of portal and nodose ganglia GLP-1 resistance following diet-induced insulin resistance, suggesting loss of this vagal GLP-1 signalling pathway may occur at the advent of diabetic dyslipidemia. The role of other gut- derived anorexigenic hormones were also investigated, and we identified that Peptide YY, oxytocin, and cholecystokinin (CCK) also exert a suppressive effect on postprandial lipoprotein metabolism. Importantly, we also delineate the effect of CCK receptor signalling from bile acid release on postprandial lipemia. This in combination with data showing CCKs effects are lost in GLP-1R KO hamsters suggests that CCK may exert its effects though bile acid-mediated increases in GLP-1 secretion. Overall, the data presented here supports a key role for GLP-1 receptors on the portal vein afferent neurons in modulating intestinal fat absorption and lipoprotein production and identifies other gut-derived peptides as novel regulators of postprandial lipemia. Insights from these data may support identification of potential drug targets for treatment of diabetic dyslipidemia.
590 $a School code: 0779.
650 4 $a Physiology. $3 518431
650 4 $a Molecular biology. $3 517296
650 4 $a Endocrinology. $3 610914
653 $a Chylomicron
653 $a Dyslipidemia
653 $a GLP-1
653 $a Insulin resistance
653 $a Vagus
690 $a 0719
690 $a 0307
690 $a 0409
710 2 $a University of Toronto (Canada). $b Laboratory Medicine and Pathobiology. $3 3193014
773 0 $t Dissertations Abstracts International $g 85-01B.
790 $a 0779
791 $a Ph.D.
792 $a 2023
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30420480